Empirical Finance, LLC Bristol Myers Squibb CO Transaction History

Empirical Finance, LLC

$1.62 Billion
Q1 2024

A detailed history of Empirical Finance, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Empirical Finance, LLC holds 77,242 shares of BMY stock, worth $3.29 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

77,242

Previous 74,719 3.38%

Holding current value

$3.29 Million

Previous $4.34 Million 3.41%

% of portfolio

0.26%

Previous 0.32%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $121,053 - $137,251	2,523 Added 3.38%	77,242 $4.19 Million
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $369,048 - $412,653	6,375 Added 9.33%	74,719 $4.34 Million
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $485,151 - $538,685	7,615 Added 12.54%	68,344 $4.37 Million
Q1 2023 Apr 05, 2023	BUY	$65.71 - $74.53 $196,735 - $223,142	2,994 Added 5.19%	60,729 $4.21 Million
Q4 2022 Jan 24, 2023	BUY	$68.48 - $81.09 $300,764 - $356,147	4,392 Added 8.23%	57,735 $4.15 Million

Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $1,066 - $630,625	8,207 Added 18.18%	53,343 $3.79 Million
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $169,930 - $187,153	2,340 Added 5.47%	45,136 $3.48 Million
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $285,513 - $342,355	4,644 Added 12.17%	42,796 $3.13 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $538,498 - $627,763	10,041 Added 35.72%	38,152 $2.38 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $92,305 - $108,123	1,560 Added 5.88%	28,111 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $227,209 - $247,431	3,670 Added 16.04%	26,551 $1.77 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $232,403 - $263,355	4,025 Added 21.35%	22,881 $1.42 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $1.08 Million - $1.2 Million	18,856 New	18,856 $1.14 Million
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $830,322 - $920,107	-14,458 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $271,304 - $317,181	4,949 Added 52.05%	14,458 $850,000
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $162,541 - $190,026	-2,965 Reduced 23.77%	9,509 $850,000
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $229,169 - $333,036	4,939 Added 65.55%	12,474 $695,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $370,797 - $483,671	7,535 New	7,535 $484,000

Others Institutions Holding BMY

# of Institutions

2,499

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $90.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Bristol Myers Squibb CO Transaction History